32 results on '"Veterinary drugs"'
Search Results
2. Exposition de la population française aux résidus de médicaments vétérinaires dans l'alimentation.
- Author
-
Bernard, Hélène, Bemrah, Nawel, Rivière, Gilles, Sanders, Pascal, and Sirot, Véronique
- Subjects
VETERINARY drug residues ,FOOD combining ,FOOD consumption ,VETERINARY medicine ,ADULT-child relationships ,PREPARED foods ,FOOD additives - Abstract
Résumé: En France, plus de 300 substances actives sont autorisées en médecine vétérinaire. Si l'évaluation du risque a priori est bien définie et l'encadrement réglementaire bien établi, la connaissance de l'exposition réelle est peu documentée. L'objectif de cette étude est d'estimer l'exposition de la population à ces résidus de médicaments et de la comparer aux doses journalières admissibles (DJA), afin d'évaluer le risque pour la population. L'exposition alimentaire de 2 624 adultes et 1 455 enfants à 215 résidus de médicaments vétérinaires a été estimée en combinant les données de consommation issues de la seconde étude individuelle nationale des consommations alimentaires (INCA 2) avec, d'une part, les limites maximales de résidus (LMR) fixées dans les aliments et, d'autre part, les données des plans de surveillance/plans de contrôle (PS/PC) de 2017 coordonnés par la Direction générale de l'alimentation (DGAL). Près de 90 % de ces données étant censurées, un scénario minimisant l'exposition et un scénario la maximisant ont été simulés. Sur 102 substances disposant d'une LMR et d'une DJA, 87 ont été recherchées dans les PS/PC. Les résultats obtenus sur la base des LMR ont été affinés par ceux obtenus par les PS/PC. Les expositions à deux antiparasitaires, le triclabendazole et l'albendazole, présentaient des dépassements de la DJA chez les enfants sous l'hypothèse haute, respectivement de 42 % et 17 %. Des suspicions existent pour 17 molécules dont les expositions n'ont pu être affinées par les résultats des PS/PC, car non analysées spécifiquement dans les matrices contribuant fortement à l'exposition alimentaire. En conclusion, l'exposition de la population aux molécules traitées est globalement inférieure aux DJA, en particulier chez les adultes, mais des suspicions de dépassements existent chez les enfants. Pour les molécules concernées, une étude de type « étude sur l'alimentation totale », c'est-à-dire dans les aliments préparés tels que consommés, permettrait de conclure. In France, more than 300 active substances are authorized in veterinary medicine. While the a priori risk has been assessed and the regulatory framework well established, knowledge of actual exposure is poorly documented. The purpose of this study is to estimate the exposure of the French population to veterinary drug residues and to compare it to the recommended acceptable daily intakes (ADI) for these substances, to determine if there is a risk for the population. The dietary exposure of 2624 adults and 1455 children to 215 veterinary medicine residues was estimated by combining consumption data from the 2
nd National Individual Study of Food Consumption (INCA 2), first with maximum residue limits (MRL) for foodstuffs, and second with the data from the 2017 report on the monitoring of veterinary medicinal product residues, managed by the French general directorate for food. Since almost 90% of these data are censored, minimal and maximal scenarios were considered. Of the 102 substances that have an MRL and an ADI, 87 were tested in monitoring programs. After refining the MRL results with those from the monitoring program, exposure to two antiparasitic treatments, triclabendazole and albendazole, significantly exceeded the ADI for children, under the high assumption, by 42 and 17%, respectively. Suspected exceedances of ADI were found for 17 molecules, whose exposures were not refined by monitoring programs because they were not specifically analyzed in matrices strongly contributing to food exposure. In conclusion, population exposure for the substances studied was lower overall than their ADI, particularly for adults. Nevertheless, suspected exceedances of ADI were identified for children. For the substances in question, a Total Diet Study (TDS)-like study, that is, a study carried out in prepared foods, would provide more conclusive results. [ABSTRACT FROM AUTHOR] more...- Published
- 2020
- Full Text
- View/download PDF
Catalog
3. Risque environnemental associé aux médicaments vétérinaires équins et à la gestion des fumiers.
- Author
-
Baudu, Michel, Charriau, Adeline, Halm-Lemeille, Marie-Pierre, Pandard, Pascal, Lissalde, Sophie, Feuillade, Geneviève, Pallier, Virginie, and Wimel, Laurence
- Subjects
VETERINARY drug residues ,SOIL amendments ,PENICILLIN G ,DRUG residues ,NONPOINT source pollution ,VETERINARY drugs ,ANTIPARASITIC agents - Abstract
Résumé: Ce projet avait pour objectif de préciser le risque environnemental associé à l'usage agronomique de composts de fumier de chevaux ayant reçu des traitements vétérinaires par une approche couplant l'évaluation de l'écotoxicité et la quantification des résidus médicamenteux. Le bilan détaillé des usages vétérinaires sur quatre années au sein d'une station expérimentale a permis de définir un protocole autour de deux événements entraînant un usage intensif de substances pharmaceutiques : la castration des jeunes chevaux et le traitement antiparasitaire annuel. Les résultats ont montré que sur six molécules utilisées pour ces opérations (un antiparasitaire, deux antibiotiques, un anesthésique, un anti-inflammatoire et un diurétique), quatre ont fait l'objet d'une quantification et seules l'ivermectine (antiparasitaire) et la pénicilline G (antibiotique administré après la castration) ont pu être quantifiées de manière significative au moment de la mise en compostage du fumier. Des bioessais sur deux organismes aquatiques (daphnie et microalgue verte) et quatre organismes terrestres ont été réalisés avec les molécules seules ou en mélange ainsi qu'avec les composts et leurs lixiviats. Les plus fortes concentrations auxquelles aucun effet n'a été observé (NOEC) à 72 heures ont été déterminées pour les deux organismes aquatiques. Les valeurs obtenues sont toutes supérieures à 1 μg/l et donc largement au-delà des concentrations environnementales, excepté pour l'ivermectine dont la NOEC est de 100 ng/l. La procaïne ne semble pas affecter les capacités de reproduction de la daphnie, mais une diminution de 52 % de la production de nouveau-nés est observée pour l'ivermectine à 10 ng/l. Une toxicité aquatique a cependant été observée lorsque les six molécules sont en mélange. En ce qui concerne les effets phytotoxiques, l'ivermectine, la dihydrostreptomycine et l'hydrochlorotiazide, pris séparément, engendrent une inhibition de la croissance racinaire sur les trois végétaux testés. Ces résultats peuvent expliquer la toxicité de certains échantillons de fumiers issus des boxes juste après traitement des chevaux. La convergence des essais de toxicité pour le compost préparé à partir du fumier ayant reçu l'ensemble des rejets des traitements ou à partir du fumier de référence permet de conclure à une absence d'effets significatifs sur le sol d'un amendement par du compost de chevaux ayant subi les traitements vétérinaires étudiés. This project uses a mixed approach — assessment of ecotoxicity and quantification of drug residues — to evaluate more accurately the environmental risk of soil amendment by horse manure compost including these veterinary drug residues. Use of veterinary drugs was assessed over 4 years and we defined an experimental protocol with two events involving intensive use of veterinary substances: the castration of young horses coupled with annual antiparasite treatment. The results showed that of the six substances used for these events (one antiparasite, two antibiotics, one anesthetic, one anti-inflammatory, and one diuretic), only ivermectin (a pesticide) and penicillin G (one of the two antibiotics given after castration) could be quantified before manure composting. Bioassays were carried out on two aquatic organisms (daphnia and green microalgae) and three terrestrial plants. The highest concentrations tested for which no effect on the organism was observed (NOEC) at 72 h were determined for the green microalgae and for the daphnia. Values were all above 1 μg/L and therefore well above the observed environmental concentrations, except for ivermectin with an NOEC of 100 ng/l. Procaine did not affect the reproductive capacity of daphnia but 10 ng/l of ivermectin led to a 52% decline in offspring. However, when the six molecules were used in "combination", aquatic toxicity was observed. Ivermectin, dihydrostreptomycin, and hydrochlorothiazide were all found to have phytotoxic effects, causing inhibition of root growth in all three plants. These results may explain the toxicity of some manure samples from stalls after veterinary treatment of horses. Overall, ecotoxicity tests on composts were similar for manure that received any or all of these treatments and control manure. No significant effect is observed on soil amended by horse manure compost following veterinary treatments. [ABSTRACT FROM AUTHOR] more...
- Published
- 2020
- Full Text
- View/download PDF
4. Traité de thérapeutique vétérinaire : pharmacodynamie, pharmacothérapie, par M. Kaufmann.
- Author
-
Kaufmann, Maurice, 1856-1924, NCSU Libraries (archive.org), and Kaufmann, Maurice, 1856-1924
- Subjects
Veterinary drugs ,Veterinary medicine ,Veterinary pharmacology - Published
- 1910
5. LA SURVEILLANCE DES MÉDICAMENTS VÉTÉRINAIRES.
- Author
-
ORAND, Jean-Pierre
- Published
- 2014
- Full Text
- View/download PDF
6. DISPONIBILITÉ DU MÉDICAMENT VÉTÉRINAIRE : RÉALITÉ, ENJEUX ET PERSPECTIVES.
- Author
-
FORTINEAU, Olivier and GAUTIER, Pauk CARNAT
- Published
- 2014
- Full Text
- View/download PDF
7. Pharmacovigilance vétérinaire : le bilan 2016 des effets indésirables chez les animaux
- Author
-
Laurentie, Sylviane, Anses ANMV (Anses ANMV), Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), and GUITTON, SOPHIE
- Subjects
[SDV] Life Sciences [q-bio] ,Pharmacovigilance ,Surveillance ,[SDV.BA.MVSA]Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health ,Veterinary drugs ,[SDV]Life Sciences [q-bio] ,[SDV.BA.MVSA] Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health ,MESH: Veterinary drugs ,Médicament vétérinaire - Abstract
International audience; Introduction : L’Anses a publié au mois de novembre 2017, son bilan d’activité de l’année 2016 pour la surveillance des médicaments vétérinaires en post autorisation de mise sur le marché (AMM). Ce rapport élaboré par l’Agence nationale du médicament vétérinaire (ANMV) présente les principaux résultats et actions concernant la surveillance du marché des médicaments vétérinaires français et la pharmacovigilance vétérinaire... more...
- Published
- 2018
8. [Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2015]
- Author
-
B. Gassner, Hanspeter Naegeli, Jacqueline Kupper, and C R Müntener
- Subjects
Gynecology ,medicine.medical_specialty ,General Veterinary ,Antiparasitic Agents ,Drug-Related Side Effects and Adverse Reactions ,Anti-Inflammatory Agents, Non-Steroidal ,Veterinary Drugs ,Dogs ,Anti-Infective Agents ,medicine ,Cats ,Animals ,Cattle ,Horses ,Switzerland - Abstract
A total of 292 adverse reactions to veterinary medicinal products were reported during the year 2015. This represents an increase of 9% compared to the previous year (268 reports). Similar to previous years, most of the reactions reported were linked to the use of antiparasitics (55.1%), non-steroidal anti-inflammatory products (8.9%) or antiinfectives (9.3%). The affected animal species were primarily dogs (198 reports) and cats (42 reports), followed by cattle (31 reports) and horses (8 reports). Additional 42 reports were provided within the frame of consultations with Tox Info Suisse in Zürich and involved mainly the excessive intake of flavored tablets. Eight signals were identified from the reports received or the periodic safety update reports. They resulted in revisions of the product information in sections addressing contraindications, adverse reactions or withdrawal times.Im Jahr 2015 wurden 292 Meldungen über unerwünschte Wirkungen eingereicht. Gegenüber dem Vorjahr (268 Meldungen) entspricht dies einer Zunahme von 9%. Wie in früheren Jahren betraf die Mehrheit der Meldungen Antiparasitika (55.1%), gefolgt von nicht-steroidalen Entzündungshemmern (8.9%) und Antiinfektiva (8.2%). Am häufigsten wurden Meldungen zu Reaktionen bei Hunden (198) und Katzen (42) eingereicht, danach folgten Rinder und Kälber (31) sowie Pferde (8). Zusätzliche 42 Fälle, die von Tox Info Suisse in Zürich übermittelt wurden, betrafen mehrheitlich die Aufnahme aromatisierter Tabletten in Überdosis. Von den 292 Meldungen und eingereichten periodischen Berichten über die Sicherheit wurden 8 Signale identifiziert, die zu einer Anpassung der Arzneimittelinformation der betroffenen Präparate in den Rubriken unerwünschte Wirkungen, Kontraindikationen oder Absetzfristen führten.En 2015, 292 annonces d’effets indésirables ont été enregistrées, ce qui correspond à une augmentation de 9% par rapport à l’année précédente (268 annonces). Comme les années passées, la majorité de ces annonces concernait des antiparasitaires (55.1%), suivis par des anti-inflammatoires non stéroïdiens (8.9%) et des antiinfectieux (8.2%). C’est chez les chiens (198) et les chats (42) que les annonces ont été les plus fréquentes, suivis par les bovins et les veaux (31) puis les chevaux (8). Quarante-deux cas supplémentaires, transmis par Tox Info Suisse à Zürich, concernaient principalement la prise en quantités exagérées de tablettes aromatisées. On a identifié, sur la base des 292 annonces et des rapports périodiques sur la sécurité reçus, 8 signaux qui ont amené à une adaptation des informations sur les médicaments dans les rubriques effets indésirables, contreindications ou délais d’attente.Nel 2015 sono state inoltrate 292 notifiche di effetti indesiderati. Rispetto allo scorso anno (268 notifiche), questo rappresenta un incremento del 9%. Come negli anni precedenti, le reazioni più importanti sono risultate dall’uso di farmaci antiparassitari (55.1%), antinfiammatori (8.9%) e antinfettivi (8.2%). Più di frequente sono state inoltrate notifiche relative alle reazioni nei cani (198) e nei gatti (42), seguite da bovini e vitelli (31) e cavalli (8). Ulteriori 42 casi, riguardanti principalmente la somministrazione di pastiglie aromatizzate in sovradosaggio, sono stati trasmessi dal servizio Tox Info Suisse di Zurigo. Tra le 292 notifiche e le relazioni periodicamente inoltrate in materia di sicurezza sono stati identificati 8 punti che hanno portato ad un adeguamento delle informazioni del preparato nella rubrica effetti indesiderati, controindicazioni e termini di attesa. more...
- Published
- 2016
9. Qualitévet : Une association au service de la profession vétérinaire
- Author
-
Éric Guaguère, Jean-François Rousselot, and Christophe Brard
- Subjects
Veterinary Drugs ,Delegate ,General Veterinary ,démarche qualité ,guide Phénix ,radioprotection ,guide de bonnes pratiques du médicament vétérinaire ,dépistage des tares oculaires ,guide de bonnes pratiques ,qualité ,business.industry ,media_common.quotation_subject ,Charter ,Public relations ,Management ,Task (project management) ,Statutory law ,Guide of good practice ,protection against X-Ray ,Quality procedures ,Phenix guide ,Quality ,detection of ocular defects ,guide of good practice of veterinary drugs ,Medicine ,Quality (business) ,Technical expert ,business ,Good practice ,media_common - Abstract
Qualitévet : an organization to help veterinarians. Qualitévet is a non-profit organization whose statutory task is to set-up and coordinate “quality” procedures that can be established within the veterinary profession and to provide institutional communication of quality procedures that apply to veterinary practice. Its Board of Directors is representative of most liberal and universitarian veterinary organizations. They delegate technical aspects of quality to an independent group of experts, the Technical Expert Board. Since its founding in 2003, Qualitévet succeeded in several major achievements : contribution to protection against X-Ray, detection of ocular defects, guide of good practice of veterinary drugs, advice for euthanasia (the Phenix guide)… Qualitévet’s ambition is to promote continuous improvement procedures for the profession, while respecting a “ quality” charter. Qualitévet aims to be a tool to help the veterinary profession., Qualitévet est une association à but non lucratif qui a pour mission statutaire d’organiser et coordonner les démarches «qualité» pouvant se mettre en place au sein de la profession vétérinaire et d’assurer la communication institutionnelle à propos de ces démarches qualité appliquées à l’exercice vétérinaire. Son conseil d’administration réunit la plupart des organismes vétérinaires libéraux ou universitaires qui délèguent les aspects techniques de la qualité à un groupe d’experts indépendants, le comité technique d’expertise. Depuis sa création, en 2003, plusieurs réalisations majeures sont à l’actif de Qualitévet : contribution à la radioprotection, au dépistage des tares oculaires, au guide de bonnes pratiques du médicament vétérinaire, aux conseils pour l’euthanasie (guide Phénix)… L’ambition de Qualitévet est de promouvoir les processus d’amélioration continue pour notre profession en respectant une charte «qualité». Qualitévet se veut être un outil au service de la profession vétérinaire., Rousselot Jean-François, Guaguère Eric, Brard Christophe. Qualitévet : Une association au service de la profession vétérinaire. In: Bulletin de l'Académie Vétérinaire de France tome 168 n°2, 2015. pp. 160-163. more...
- Published
- 2015
10. The role of veterinary medicine regulatory agencies
- Author
-
M V, Smith
- Subjects
Veterinary Medicine ,Food Safety ,Legislation, Veterinary ,Government ,Animals ,Humans ,Veterinary Drugs ,Legislation, Drug - Abstract
An effective animal medicine regulatory programme includes a systematic, evidence-based means of documenting the safety and effectiveness of products before they are produced, marketed or used in a particular country or region. The programme must also include adequate monitoring and controls over the use of these substances. It is clearthat such programmes provide veterinarians, farmers and other animal medicine users with greater assurance that veterinary drugs and biologicals will be safe and effective in preventing and mitigating disease. It is important that these regulatory controls include programmes to ensure that human food obtained from treated animals is safe and that all potential toxicological and microbiological hazards that may be associated with the use of veterinary medicines have been adequately evaluated. There is a great need worldwide for veterinary medicines that provide needed therapies for vast numbers of animals and animal species and, in the case of food-producing animals, for medicinal products that enhance the productivity and efficiency of food production and ensure food safety when they are used in accordance with their approval specifications. The public health mission of regulatory agencies succeeds when they are able to put into the hands of the user an approved, safe and effective, well-manufactured and appropriately labelled medicine, and when there are adequate controls in place to assure proper compliance. more...
- Published
- 2014
11. Antimicrobial resistance and the standards of the World Organisation for Animal Health
- Author
-
Orand Jp
- Subjects
Risk analysis ,Veterinary Drugs ,United Nations ,media_common.quotation_subject ,Legislation ,Guidelines as Topic ,Biology ,World Health Organization ,Risk Assessment ,Antibiotic resistance ,Anti-Infective Agents ,Zoonoses ,Animals ,Humans ,Quality (business) ,Animal Husbandry ,media_common ,Strategic planning ,Animal health ,business.industry ,Legislation, Veterinary ,Health Policy ,International Agencies ,Drug Resistance, Microbial ,General Medicine ,Public relations ,Biotechnology ,Agriculture ,Animal Science and Zoology ,business - Abstract
Antimicrobial resistance and the use of antimicrobial agents in veterinary medicine are complex issues that are currently a source of major international concern. It is therefore essential for the World Organisation for Animal Health (OIE) to consider this issue, while at the same time continuing to address the problem of zoonotic diseases. That is why the OIE has included objectives for veterinary drugs, especially antimicrobials, in its Strategic Plan. The OIE plays an active part in discussions on this subject in conjunction with other international organisations working in this field, such as the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO). Furthermore, the OIE has adopted guidelines both for defining harmonised methodologies for antimicrobial resistance surveillance and monitoring and for helping countries to conduct a risk analysis tailored to their situation and to take appropriate management measures. The OIE has included this issue in its programme of assistance to countries by offering them structural enhancement tools: the Tool for the Evaluation of Performance of Veterinary Services (O1E PVS Tool), PVS Gap Analysis, veterinary legislation support, and training for veterinary national focal points, with the aid of its Collaborating Centres for veterinary medicinal products. Only by mobilising all countries to improve the quality of antimicrobials, to introduce antimicrobial resistance surveillance and to implement measures for the responsible and prudent use of antimicrobials, will it be possible to halt the spread of antimicrobial resistance. more...
- Published
- 2012
12. [A pharmacist designer and manufacturer of veterinarian patent medicines, Paul Méré, de Chantilly]
- Author
-
Paul, Méré
- Subjects
Veterinary Medicine ,Pharmaceutical Preparations ,History of Pharmacy ,Animals ,Veterinary Drugs ,History, 19th Century ,France ,Horses ,Pharmacists ,Sports ,Veterinarians - Abstract
In the last quarter of the 19th century, Paul Méré, pharmacist in Chantilly (Oise), worked out and marketed a range of veterinarian medicines mainly intended for horses. He pursued his activity in Orleans (Loiret), giving her a big extension with export of his patents medicines in numerous foreign countries, this company having remained up to the Second World War. more...
- Published
- 2012
13. [Update on the Mali Pharmacy Code: legislative section]
- Author
-
S, Maiga, B, Haidara, O, Thioune, B, N'diaye, C S B, Boye, and I, Lo
- Subjects
Quality Control ,Pharmacies ,Pharmacy Administration ,Drug Storage ,Veterinary Drugs ,Legislation, Drug ,Mali ,Pharmaceutical Preparations ,Equipment and Supplies ,Education, Pharmacy ,Plant Preparations ,Laboratories ,Medicine, African Traditional ,Legislation, Pharmacy ,Licensure, Pharmacy - Abstract
Due to colonization (1895-1960) Mali has been submitted, on the legislative and regulation plan to a corpus of numerous and scattered texts relative to pharmacy. It is essentially the Law AN XI of 21 Germinal or the 11 April 1803 Law; the content of Book V of the Public Health Code relative to pharmacy practice, of which some disposals have been extended to Overseas Territories, Togo and Cameroon in 1953; the 1955 Ministerial Order about the dispatching of the Retail Pharmacy in AOF; the 1960 Law creating the Board of Pharmacists in the Federation of Mali etc. After independence, the new Malian State while renewing the pharmacy legislation issued by the old tutor State which was not opposed to the new fundamental Law, has also set up, according to the political orientations of the moment, some new texts. In the framework of this work, we have collected all the legislative and regulation texts that have been allowed in Mali in the pharmacy area and in that of Studies in Pharmacy. We have examined those texts and proceeded to codify the legislative part. The present Code consists of 189 articles divided in 5 titles layed out in chapters and sections. more...
- Published
- 2011
14. Health Canada's policy on extra-label drug use in food-producing animals in Canada
- Author
-
Grignon-Boutet, Renée, Ireland, Mary-Jane, Adewoye, Lateef, Mehrotra, Manisha, Russell, Susan, and Alexander, Ian
- Subjects
Canada ,Meat ,Legislation, Veterinary ,Risk Factors ,Humans ,Veterinary Drugs ,Scientific ,Public Health ,Legislation, Food ,Legislation, Drug ,Drug Residues ,Features - Published
- 2008
15. Pharmacogenetics: it's not just about ivermectin in collies
- Author
-
Patricia, Dowling
- Subjects
Dogs ,Species Specificity ,Blood-Brain Barrier ,Pharmacogenetics ,Animals ,Veterinary Drugs ,ATP Binding Cassette Transporter, Subfamily B, Member 1 ,Dog Diseases ,Genes, MDR ,Features ,Pedigree - Published
- 2007
16. Le Guide de Bonnes Pratiques du Médicament vétérinaire dans les cabinets vétérinaires : un référentiel, une démarche qualité
- Author
-
Jacqueline Bastien Ceret
- Subjects
Reference Document ,guide de Bonnes Pratiques ,médicament vétérinaire ,mise en place ,Veterinary Drugs ,General Veterinary ,Quality control system ,business.industry ,Technical service ,Agency (sociology) ,Animal production ,Public relations ,business ,Good Practice Guide ,veterinary drugs ,implementation ,Pharmaceutical industry - Abstract
Veterinary drugs are the focus of attention of the animal production industry, the pharmaceutical industry, veterinarians and consumers. To provide answers to their concerns, the SNGTV (National Agency of Veterinary Technical Service Providers) has decided to create a system promoting good practices for veterinary drugs. This system has lead to the creation of a recognised reference document : the Good Practice Guide for Veterinary Drugs. The objective was to recruit a maximum of veterinary practices, to gain recognition for those committed, and to communicate on this collective commitment to all the industries concerned. This article reviews the bases on which this guide is founded, and how its guidelines can be implemented in veterinary practices. The objectives are presented : to professionalize the management and use of veterinary drugs and to guarantee their safe use both individually and collectively, using a quality control system validated by Qualitevet., Le médicament vétérinaire est au carrefour des préoccupations des filières de productions animales, de l’industrie pharmaceutique, des vétérinaires et des consommateurs. Pour répondre à ces préoccupations, la Société nationale des Groupements techniques vétérinaires (SNGTV) a décidé de mettre en place une démarche visant à promouvoir les bonnes pratiques du médicament vétérinaire dans les cabinets vétérinaires. Cette démarche a conduit à concevoir un référentiel reconnu : le Guide de Bonnes Pratiques (GBP) du médicament vétérinaire. L’objectif est de faire engager un maximum de cabinets vétérinaires dans cette démarche, de faire reconnaître ceux qui sont engagés et de pouvoir communiquer auprès de l’ensemble des filières sur cet engagement collectif. Cet article expose sur quelles bases ce guide a été élaboré et comment la démarche GBP peut être mise en place dans un cabinet vétérinaire. Les objectifs sont présentés : professionnaliser la gestion et l’utilisation du médicament vétérinaire, apporter des garanties sur une utilisation sécurisée, tant au niveau individuel qu’au niveau collectif, par un engagement dans une reconnaissance validée par Qualitévet., Bastien Jacqueline. Le Guide de Bonnes Pratiques du Médicament vétérinaire dans les cabinets vétérinaires : un référentiel, une démarche qualité. In: Bulletin de l'Académie Vétérinaire de France tome 158 n°2, 2005. pp. 145-151. more...
- Published
- 2005
17. [Hippiatric formularies established during the period of the Revolution]
- Author
-
F, Trépardoux
- Subjects
Pharmacopoeias as Topic ,Warfare ,Animals ,Veterinary Drugs ,France ,Horses ,History, 18th Century ,State Medicine - Abstract
Two hippiatric formularies established during the period of the Revolution are presented. The first one published in 1793, is a printed pamphlet of 8 pages, containing 68 drugs. The second one dated of january 1794 includes 26 items only, and consists in a unique chart entitled: Nomenclature des Drogues nécessaires au traitement des maladies internes et externes des chevaux malades qui sont aux armées et dans les différents dépôts de la République. This is of particular and new interest when it tentatively synthesizes and standardizes the main pharmaceutical products able of fighting farcy and glanders. After the first work carried out by Bourgelat around 1760, it confirms the necessity of reforming the ancient and often useless polypharmacy, by selecting efficient drugs and in advising about their relevant use. more...
- Published
- 2003
18. An update from the Veterinary Drugs Directorate
- Author
-
Diane, Kirkpatrick
- Subjects
Veterinary Medicine ,Canada ,Animals ,Humans ,Veterinary Drugs ,Features - Published
- 2002
19. One-stop shopping: retailing in veterinary practice
- Author
-
J D, Stowe
- Subjects
Marketing of Health Services ,Veterinary Medicine ,Financial Management ,Animals ,Veterinary Drugs ,Research Article - Published
- 1998
20. The role of veterinary medicine regulatory agencies.
- Author
-
Smith MV
- Subjects
- Animals, Food Safety, Government, Humans, Legislation, Drug, Legislation, Veterinary, Veterinary Drugs, Veterinary Medicine standards
- Abstract
An effective animal medicine regulatory programme includes a systematic, evidence-based means of documenting the safety and effectiveness of products before they are produced, marketed or used in a particular country or region. The programme must also include adequate monitoring and controls over the use of these substances. It is clearthat such programmes provide veterinarians, farmers and other animal medicine users with greater assurance that veterinary drugs and biologicals will be safe and effective in preventing and mitigating disease. It is important that these regulatory controls include programmes to ensure that human food obtained from treated animals is safe and that all potential toxicological and microbiological hazards that may be associated with the use of veterinary medicines have been adequately evaluated. There is a great need worldwide for veterinary medicines that provide needed therapies for vast numbers of animals and animal species and, in the case of food-producing animals, for medicinal products that enhance the productivity and efficiency of food production and ensure food safety when they are used in accordance with their approval specifications. The public health mission of regulatory agencies succeeds when they are able to put into the hands of the user an approved, safe and effective, well-manufactured and appropriately labelled medicine, and when there are adequate controls in place to assure proper compliance. more...
- Published
- 2013
- Full Text
- View/download PDF
21. [A pharmacist designer and manufacturer of veterinarian patent medicines, Paul Méré, de Chantilly].
- Author
-
Devaux G
- Subjects
- Animals, France, History, 19th Century, Horses, Pharmaceutical Preparations, Pharmacists, Sports, Veterinarians, Veterinary Drugs, History of Pharmacy, Veterinary Medicine history
- Abstract
In the last quarter of the 19th century, Paul Méré, pharmacist in Chantilly (Oise), worked out and marketed a range of veterinarian medicines mainly intended for horses. He pursued his activity in Orleans (Loiret), giving her a big extension with export of his patents medicines in numerous foreign countries, this company having remained up to the Second World War. more...
- Published
- 2012
22. [Update on the Mali Pharmacy Code: legislative section].
- Author
-
Maiga S, Haidara B, Thioune O, N'diaye B, Boye CS, and Lo I
- Subjects
- Drug Storage standards, Education, Pharmacy legislation & jurisprudence, Equipment and Supplies, Laboratories legislation & jurisprudence, Laboratories standards, Legislation, Drug, Licensure, Pharmacy legislation & jurisprudence, Mali, Pharmacies legislation & jurisprudence, Pharmacies organization & administration, Pharmacy Administration legislation & jurisprudence, Veterinary Drugs, Legislation, Pharmacy
- Abstract
Due to colonization (1895-1960) Mali has been submitted, on the legislative and regulation plan to a corpus of numerous and scattered texts relative to pharmacy. It is essentially the Law AN XI of 21 Germinal or the 11 April 1803 Law; the content of Book V of the Public Health Code relative to pharmacy practice, of which some disposals have been extended to Overseas Territories, Togo and Cameroon in 1953; the 1955 Ministerial Order about the dispatching of the Retail Pharmacy in AOF; the 1960 Law creating the Board of Pharmacists in the Federation of Mali etc. After independence, the new Malian State while renewing the pharmacy legislation issued by the old tutor State which was not opposed to the new fundamental Law, has also set up, according to the political orientations of the moment, some new texts. In the framework of this work, we have collected all the legislative and regulation texts that have been allowed in Mali in the pharmacy area and in that of Studies in Pharmacy. We have examined those texts and proceeded to codify the legislative part. The present Code consists of 189 articles divided in 5 titles layed out in chapters and sections. more...
- Published
- 2010
23. [Burglary prevention in animal clinics].
- Author
-
Metzger B
- Subjects
- Animals, Equipment and Supplies, Humans, Switzerland, Veterinary Drugs, Crime prevention & control, Hospitals, Animal
- Published
- 2007
- Full Text
- View/download PDF
24. An update from the Veterinary Drugs Directorate.
- Author
-
Kirkpatrick D
- Subjects
- Animals, Canada, Humans, Veterinary Drugs, Veterinary Medicine organization & administration
- Published
- 2002
25. [Acute pentobarbital poisoning].
- Author
-
Résière D, Mégarbane B, Manet P, Buisine A, and Hilpert F
- Subjects
- Diagnosis, Differential, Fatal Outcome, Hemoperfusion, Humans, Male, Middle Aged, Suicide, Veterinary Drugs, Hypnotics and Sedatives poisoning, Pentobarbital poisoning
- Published
- 2001
26. [Hippiatric formularies established during the period of the Revolution].
- Author
-
Trépardoux F
- Subjects
- Animals, France, History, 18th Century, Horses, Pharmacopoeias as Topic, State Medicine, Veterinary Drugs, Warfare
- Abstract
Two hippiatric formularies established during the period of the Revolution are presented. The first one published in 1793, is a printed pamphlet of 8 pages, containing 68 drugs. The second one dated of january 1794 includes 26 items only, and consists in a unique chart entitled: Nomenclature des Drogues nécessaires au traitement des maladies internes et externes des chevaux malades qui sont aux armées et dans les différents dépôts de la République. This is of particular and new interest when it tentatively synthesizes and standardizes the main pharmaceutical products able of fighting farcy and glanders. After the first work carried out by Bourgelat around 1760, it confirms the necessity of reforming the ancient and often useless polypharmacy, by selecting efficient drugs and in advising about their relevant use. more...
- Published
- 2000
27. Concerns about recommending over-the-counter drugs to treat helminthiasis.
- Author
-
Gagnon C
- Subjects
- Animals, Anthelmintics economics, Dogs, Drug Costs, Nonprescription Drugs economics, Anthelmintics therapeutic use, Dog Diseases drug therapy, Helminthiasis, Animal drug therapy, Nonprescription Drugs therapeutic use, Veterinary Drugs, Veterinary Medicine standards
- Published
- 1999
28. Re-engineering the Bureau of Veterinary Drugs.
- Author
-
McKelvey D
- Subjects
- Canada, Drug Approval economics, Government Agencies organization & administration, Veterinary Drugs
- Published
- 1998
29. Crisis at the Bureau of Veterinary Drugs.
- Author
-
McCall E
- Subjects
- Canada, Government Agencies organization & administration, Veterinary Drugs
- Published
- 1998
30. Distribution du médicament vétérinaire dans les pays en voie de développement
- Author
-
M. Lobry
- Subjects
Pharmacie vétérinaire ,Pays en voie de développement ,Veterinary drugs ,Developing countries ,General Veterinary - Abstract
Distribution of veterinary drugs in developing countries. At the time animal husbandry is improving in developing countries and veterinary medicinal products trade is on the increase, it is essential to rationalize the use of the latter. That is the reason why the Govemements are paying more and more attention to drawing legislations and regulations on quality requirements at production, marketing authorization and distribution stages. The distribution of veterinary drugs has to face some specific problems in developing countries where every regulation should take into account the local conditions. A pragmatic attitude is recommended by the author, trying to avoid monopolies in distribution. However the State should not renounce its responsability in protecting public health, regulating and coordinating mainly at the stage of import of veterinary drugs, and, where this happens, of production., Au moment où s’améliore l’élevage dans les pays en voie de développement, où s’intensifie le commerce des médicaments vétérinaires, il importe de rationaliser l’utilisation de ces derniers. C’est pourquoi les Etats accordent leur attention à l’élaboration de législation visant à codifier les normes de qualités relatives à la fabrication, la mise sur le marché et de la distribution de ces produits. La distribution pose des problèmes particuliers dans les pays en voie de développement où toute réglementation devra s’attacher à tenir compte des conditions locales. L’auteur recommande une attitude pragmatique tendant à éviter les monopoles de distribution. L’Etat ne saurait toutefois abandonner son rôle de protection de la santé publique, de régulation et de coordination surtout au niveau de l’importation des produits et, là où elle se pratique, de la production., Lobry M. Distribution du médicament vétérinaire dans les pays en voie de développement. In: Bulletin de l'Académie Vétérinaire de France tome 141 n°2, 1988. pp. 185-190. more...
- Published
- 1988
31. [Injectable veterinary soluble drugs. II. Excipients, active principles, tests]
- Author
-
J R, DESVAUX
- Subjects
Excipients ,Veterinary Medicine ,Humans ,Medicine ,Veterinary Drugs - Published
- 1956
32. [Injectable veterinary soluble drugs. II. Excipients, active principles, tests].
- Author
-
DESVAUX JR
- Subjects
- Humans, Excipients, Medicine, Veterinary Drugs, Veterinary Medicine
- Published
- 1956
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.